| # | Drug | Count |
|---|---|---|
| 0 | BLEOMYCIN | 4 |
| 1 | BLEOMYCIN SULFATE | 4 |
| 2 | CISPLATIN | 4 |
| 3 | ETOPOSIDE | 4 |
| 4 | AZACITIDINE | 1 |
| 5 | CYTARABINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLEOMYCIN SULFATE | 4 | 0.0004 |
| 1 | ETOPOSIDE | 4 | 0.0001 |
| 2 | CISPLATIN | 4 | 0.0001 |
| 3 | AZACITIDINE | 1 | 0.0000 |
| 4 | CYTARABINE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 4 |
| 1 | Topoisomerase Inhibitor [EPC] | 4 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |